Evidence mapPaperPMID 41709969Full record

ReviewJournal of inflammation research2026

Macrophage Hypoxia Signaling Pathways and Their Roles in Sepsis.

Mu Yuan, Lixing Tian, Xiang Xu

Abstract readReview
In one paragraph

Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mu YuanDepartment of Stem Cell and Regenerative Medicine, National Key Laboratory of Trauma and Chemical Poisoning, Army Characteristic Medical Center, Army Medical University, Yuzhong District, Chongqing, 400042, People's Republic of China.ORCID 0009-0006-9418-1800
Lixing Tian *Department of Stem Cell and Regenerative Medicine, National Key Laboratory of Trauma and Chemical Poisoning, Army Characteristic Medical Center, Army Medical University, Yuzhong District, Chongqing, 400042, People's Republic of China.ORCID 0009-0002-0862-4574
Xiang Xu *Department of Stem Cell and Regenerative Medicine, National Key Laboratory of Trauma and Chemical Poisoning, Army Characteristic Medical Center, Army Medical University, Yuzhong District, Chongqing, 400042, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a severe systemic inflammatory response syndrome, and macrophages play a crucial role in its pathogenesis. In recent years, more and more attention has been paid to the molecular signaling pathways of hypoxia, especially hypoxia-inducible factor 1-alpha (HIF-1α) and its related metabolic reprogramming, which have shown their importance in regulating the inflammatory response and functional state of macrophages. At present, although a large number of studies have explored the functional changes of macrophages in sepsis, there are still many unsolved mysteries about the specific mechanism and clinical significance of the effect of hypoxia signaling pathway on macrophage function and disease progression. In this review, the metabolic pathways regulated by HIF-1α, the activation of inflammasomes, the reprogramming of cell functions, and the effects of hypoxia-related signaling pathways on macrophage function and the pathological process of sepsis were summarized. Combined with the latest single-cell transcriptomics data and molecular mechanism research, we systematically explore the potential therapeutic targets and intervention strategies, which provide theoretical basis and research direction for the precise treatment of sepsis.

Indexed as

HIF-1αhypoxiainflammasomemacrophagesmetabolic reprogrammingsepsistherapeutic target

Identifiers

PMID41709969
PMCPMC12912179

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.